您所在的位置: 首页 > 雅思 > 雅思真题

雅思阅读模拟试题(3)

作者:新通教育

2016-02-17 新通教育

对于正在备考2016年雅思考试的考生来说,高质量的雅思考试模拟题是必不可少的雅思复习资料,新通教育为大家奉上2016年最新雅思考试模拟题,希望对大家的雅思备考有帮助。

  1. The failure of a high-profile cholesterol drug has thrown a spotlight on the complicated machinery that regulates cholesterol levels. But many researchers remain confident that drugs to boost levels of ’good’ cholesterol are still one of the most promising means to combat spiralling heart disease. 

  2. Drug company Pfizer announced on 2 December that it was cancelling all clinical trials of torcetrapib, a drug designed to raise heart-protective high-density lipoproteins (HDLs)。 In a trial of 15000 patients, a safety board found that more people died or suffered cardiovascular problems after taking the drug plus a cholesterol-lowering statin than those in a control group who took the statin alone. 

  3. The news came as a kick in the teeth to many cardiologists because earlier tests in animals and people suggested it would lower rates of cardiovascular disease. “There have been no red flags to my knowledge,” says John Chapman, a specialist in lipoproteins and atherosclerosis at the National Institute for Health and Medical Research (INSERM) in Paris who has also studied torcetrapib. “This cancellation came as a complete shock.” 

  4. Torcetrapib is one of the most advanced of a new breed of drugs designed to raise levels of HDLs, which ferry cholesterol out of artery-clogging plaques to the liver for removal from the body. Specifically, torcetrapib blocks a protein called cholesterol ester transfer protein (CETP), which normally transfers the cholesterol from high-density lipoproteins to low density, plaque-promoting ones. Statins, in contrast, mainly work by lowering the ’bad’ low-density lipoproteins. 

  Under pressure 

  5. Researchers are now trying to work out why and how the drug backfired, something that will not become clear until the clinical details are released by Pfizer. One hint lies in evidence from earlier trials that it slightly raises blood pressure in some patients. It was thought that this mild problem would be offset by the heart benefits of the drug. But it is possible that it actually proved fatal in some patients who already suffered high blood pressure. If blood pressure is the explanation, it would actually be good news for drug developers because it suggests that the problems are specific to this compound. Other prototype drugs that are being developed to block CETP work in a slightly different way and might not suffer the same downfall. 

  6. But it is also possible that the whole idea of blocking CETP is flawed, says Moti Kashyap, who directs atherosclerosis research at the VA Medical Center in Long Beach, California. When HDLs excrete cholesterol in the liver, they actually rely on LDLs for part of this process. So inhibiting CETP, which prevents the transfer of cholesterol from HDL to LDL, might actually cause an abnormal and irreversible accumulation of cholesterol in the body. “You’re blocking a physiologic mechanism to eliminate cholesterol and effectively constipating the pathway,” says Kashyap. 

  Going up 

  7. Most researchers remain confident that elevating high density lipoproteins levels by one means or another is one of the best routes for helping heart disease patients. But HDLs are complex and not entirely understood. One approved drug, called niacin, is known to both raise HDL and reduce cardiovascular risk but also causes an unpleasant sensation of heat and tingling. Researchers are exploring whether they can bypass this side effect and whether niacin can lower disease risk more than statins alone. Scientists are also working on several other means to bump up high-density lipoproteins by, for example, introducing synthetic HDLs. “The only thing we know is dead in the water is torcetrapib, not the whole idea of raising HDL,” says Michael Miller, director of preventive cardiology at the University of Maryland Medical Center, Baltimore. 

  (613 words nature) 

  Questions 1-7 

  This passage has 7 paragraphs 1-7. 

  Choose the correct heading for each paragraph from the list of headings below. 

  Write the correct number i-ix in boxes 1-7 on your answer sheet. 

  List of Headings 

  i. How does torcetrapib work? 

  ii. Contradictory result prior to the current trial 

  iii. One failure may possibly bring about future success 

  iv. The failure doesn’t lead to total loss of confidence 

  v. It is the right route to follow 

  vi. Why it’s stopped 

  vii. They may combine and theoretically produce ideal result 

  viii. What’s wrong with the drug 

  ix. It might be wrong at the first place 

  Example answer 

  Paragraph 1 iv 

  1. Paragraph 2 

  2. Paragraph 3 

  3. Paragraph 4 

  4. Paragraph 5 

  5. Paragraph 6 

  6. Paragraph 7 

  Questions 7-13 

  Match torcetrapib,HDLs,statin and CETP with their functions (Questions 8-13)。。 

  Write the correct letter A, B, C or D in boxes 8-13 on your answer sheet. 

  NB You may use any letter more than once. 

  7.It has been administered to over 10,000 subjects in a clinical trial. 

  8.It could help rid human body of cholesterol. 

  9.Researchers are yet to find more about it. 

  10. It was used to reduce the level of cholesterol. 

  11. According to Kashyap, it might lead to unwanted result if it’s blocked. 

  12. It produced contradictory results in different trials. 

  13. It could inhibit LDLs. 

  List of choices 

  A. Torcetrapic 

  B. HDLS 

  C. Statin 

  D. CETP 

  Suggested Answers and Explanations 

  1. vi 

  2. ii 

  3. vii 本段介绍了torcetrapib和statin的治病原理,但是同时短语“in contrast”与之前第二段后半段的内容呼应,暗示了这两种药在理论上能相辅相成,是理想的搭配。第一个选项无法涵盖整段意义,故选择i是错误的。 

  4. iii 本段分析了可能导致torcetrapibl临床试验失败的原因,后半段指出如果以上推测正确,那么未来的药物可借鉴这个试验,设法避免torcetrapib的缺陷,研制出有效的药物。viii选项无法涵盖后半段的意思。 

  5. ix 见首句。 

  6. v 

  7. A 见第二段。题目中administer一词意为“用药”,subject一词为“实验对象”之意。 

  8. B 见第四段“… to raise levels of HDLs, which ferry cholesterol out of artery- clogging plaques to the liver for removal from the body.”即HDLs的作用最终是将 choleserol清除出人体:“… for removal from the body”。 

  9. B 见第四段“But HDLs are complex and not entirely understood.” 

  10. C 见第二段“… plus a cholesterol-lowering statin”,即statin是可以降低cholesterol的。 

  11. D 见第六段 “So inhibiting CETP, … might actually cause an abnormal and irreversible accumulation of cholesterol in the body. 

  12. A 见第三段。 

  13. C 见第四段“Statins, in contrast, mainly work by lowering the ’bad’ low-density lipoproteins 
 

雅思 保分课程

课程名称 学习目标 班级特色
雅思5.5分钻石小班 雅思5.5分 夯实基础综合提高 报名
雅思6.5分冲刺9人班 保6冲6.5分 名师课程超低价格 报名
雅思考前冲刺班 冲刺7分 短期集训冲刺高分 报名
雅思基础VIP1V1课程 个人定制 针对个人量身定制课程 报名
雅思VIP高端定制7分班 保6.5争7分 小班保分通过 报名
雅思考前点题班(周末) 雅思6.5分 助教全程跟进服务升级 报名

更多分享

剑桥雅思真题系列免费打包下载
  • 剑桥雅思官方真题4-11合集

    免费下载

    格式: doc 大小:20.0MB

    免费下载
  • 剑桥雅思听力考试真题合集

    免费下载

    格式: doc 大小:26.5MB

    免费下载
  • 剑桥雅思写作高分范文合集

    免费下载

    格式: doc 大小:612KB

    免费下载
语培留学服务
  • 考试提醒
  • 报名
  • 考试
  • 查分
2019年雅思考试报名时间

近期考试:1月5日 1月12日 1月17日 1月19日 1月26日

近期考试:1月5日 1月12日 1月17日 1月19日 1月26日

2019年雅思成绩查询入口

近期考试:1月5日 1月12日 1月17日 1月19日 1月26日

  • 考前预测
  • 名师押题 缩小范围100%命中